# Development of Ivermectin for Alcohol Use Disorders

> **NCT02046200** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of California, Los Angeles** · enrollment: 11 (actual)

## Conditions studied

- Alcohol Use Disorder

## Interventions

- **DRUG:** Ivermectin
- **DRUG:** Placebo
- **DRUG:** Alcohol

## Key facts

- **NCT ID:** NCT02046200
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2018-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02046200

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02046200, "Development of Ivermectin for Alcohol Use Disorders". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02046200. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*